Articles - biotech and pharmacy
Politics versus facts
1.9.2010 | Articles - biotech and pharmacy
The start of new technologies was never easy. From to-day bureaucratic vocabulary we can say that new achievements always met “precautionary principle”. This is a box available for whole set of wild catastrophic scenarios.
Slowing U.S. Economic Recovery & The Environmental Biotech Industry
25.8.2010 | Articles - biotech and pharmacy
In late July, Federal Reserve Chairman Ben Bernanke testified before Congress concerning monetary policy actions and the general economic recovery in the United States. In his testimony he stated the economic outlook in the U.S. is “unusually uncertain.” This very dovish outlook from the Federal Reserve caused a wave of risk aversion to...
Cellular armature against HIV
18.8.2010 | Articles - biotech and pharmacy
A group of Spanish scientists headed by Felix Goñi found out a new way how to decrease the number of HIV positive people in our population (Vieira et al., 2010). According to their study we could stop the process of the fusion of the cell and the HIV in a new way.
Inherited clubfoot can be associated with chromosomal abnormality
20.7.2010 | Articles - biotech and pharmacy
Clubfoot is a relatively common congenital anomaly of the lower extremity. The etiology of this anomaly is believed to be multifactorial – so both exogenous and genetic factors can be involved. The recent study shows a possible connection of the inherited clubfoot form with structural chromosomal aberration on the chromosome 17...
Past, presence and future of the surveillance of the congenital anomalies
16.7.2010 | Articles - biotech and pharmacy
Congenital anomalies monitoring systems and surveillance programs were created in many countries during the 20th century. Their main goal was to identify potential teratogenic threats that may affect the general population. Today these organizations have many new duties that should decrease incidences of congenital anomalies in n...
New drug could improve the learning ability of individuals with Down syndrome
6.7.2010 | Articles - biotech and pharmacy
Researchers from Texas might be able to help the children with Down syndrom some day. They found out, that there may be a protein responsible for the impairment of cognitive functions. This protein belongs to amyloids, which are pathological protein aggregates with specific properties. Abnormal accumulation of amyloid leads to many diseases. In...
Scientists develop new method to identify glycosylated proteins
8.6.2010 | Articles - biotech and pharmacy
Various processes in our body are controlled by subsequent changes of proteins. Therefore, the identification of such modifications is essential for the further exploration of the human organism. Scientists of the Max Planck Institute of Biochemistry in Martinsried (Germany), have developed a new method that allows identify more than 6,000...
Peptides which can fix the heart
1.6.2010 | Articles - biotech and pharmacy
The new research of scientists from New York and Boston shows, that peptide-based drugs could be useful in stimulating the growth and proliferation of heart cells, so they could be a great help for patients who have suffered a damage on the heart.
Anti-malarial drug chloroquine
6.5.2010 | Articles - biotech and pharmacy
Researchers at George Mason University's Center for Applied Proteomics and Molecular Medicine (CAPMM) and Inova Breast Care Institute (IBCI) are trying to prove, if a drug that has been used to treat malaria for years can possibly be used to treat pre-invasive breast cancer before it becomes invasive.
- Search in databases:
- Organizations
- Projects
- Links
- Books
- Journals
- Legislative
- Events
